Life Expectancy After Liver Transplantation for Alcoholic Cirrhosis

Area of Science:

• Hepatology
• Transplantation Medicine
• Public Health

Background:

• Alcohol-associated liver disease (ALD) is the primary indication for liver transplantation in Western countries.
• Assessing long-term survival and life expectancy in ALD patients post-transplant is crucial for patient management.

Purpose of the Study:

• To calculate life expectancies for liver transplant recipients with ALD.
• To identify risk factors influencing survival.
• To determine if survival rates have improved in recent years.

Main Methods:

• Analysis of data from 14,962 ALD patients undergoing liver transplantation (2002-2018) from the US Organ Procurement and Transplantation Network.
• Utilized Cox proportional hazards regression and life table methods for survival analysis.

Main Results:

• Key survival factors include patient age, diabetes, hepatic encephalopathy, and hospital stay duration.
• Survival demonstrated improvement over the study period: ~3% annually in the first 5 years post-transplant, then ~1% annually thereafter.
• Life expectancy was significantly lower than the general population, varying by individual risk factors.

Conclusions:

• Life expectancy for ALD liver transplant recipients is substantially reduced but shows modest improvement over time.
• Patient longevity is influenced by age, comorbidities, and functional status.
• Understanding survival trends aids in optimizing treatment and decision-making for ALD patients.